ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SUMM Summit Therapeutics Plc

20.50
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Summit Therapeutics Plc LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.50 18.00 23.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Summit Therapeutics Share Discussion Threads

Showing 38626 to 38646 of 41850 messages
Chat Pages: Latest  1554  1553  1552  1551  1550  1549  1548  1547  1546  1545  1544  1543  Older
DateSubjectAuthorDiscuss
09/8/2017
15:36
Thanks football ... tuned in.
hugus maximus
09/8/2017
15:34
is it working?
waterloo01
09/8/2017
15:21
Anyone connected ?

Now ok.

chrisatrdg
09/8/2017
11:58
My thoughts too waterloo01 when I heard it at the AGM - nothing unusual.May get an update question today under the question & answer section.
chrisatrdg
09/8/2017
11:12
Indian summers usually refer to a late summer heat in Sept/Oct.
waterloo01
09/8/2017
07:44
Looking forward to listening in at 3:30 today.Meanwhile on AIM, Technical observers will likely be eyeing an imminent Cup & Handle completion and hopefully lifting us through resistance in the next few days. There was a small tick-up in volume yesterday.......
tightfist
08/8/2017
18:45
Lol, who can tell though if the DMD treatment proves itself then the £2 share price will be a thing of the past....happy to see a share price of £10 which is possible...
bewise2
08/8/2017
18:01
bewise2 so it's a 10 bagger from here on in with that £20+ price then
football
08/8/2017
15:33
NASDAQ & AIM looking good today hopefully it will hold.

Hoping for some positive information from this Wednesday's conference (3.30 UK Time) - the questions from the floor are usually interesting & gives us an idea as to what others are thinking.

chrisatrdg
08/8/2017
08:26
Observation: Over the past few days the NADAQ has moved solidly up during the trading day (yesterday up toward $14.8 by end of play) then in the last couple of minutes, it slams way back down (yesterday falling well below the opening price)

Question: Is there an AIM Market Master type scenario at play on the NASDAQ where the market can be pushed up and down in order for it's controllers to make money? (i.e. In the way that trades aren't reported as they actually happen etc?)

hugus maximus
07/8/2017
20:49
Momentum building stateside now as we approach:

A possible cdiff announcement

The DMD results Q1!

Speculation on Sarepta next move re SMMT!

A share price of £20+ would be nice, one can always hope!

bewise2
05/8/2017
11:11
$15 on the NASDAQ next week then?!
hugus maximus
04/8/2017
08:19
Back to basics - If the current AIM & NASDAQ share price can hold it now makes for a good platform for the next stage i.e £2.50 ASK.Hopefully I am not dreaming but with currently sound science this share must now start to progress if it is going to at all.
chrisatrdg
03/8/2017
18:40
Goodness Hugus that's even more obtuse than my allusion
freedosh
03/8/2017
12:08
RNS out and is about


Summit Therapeutics plc Summit Therapeutics To Present At The Canaccord Genuity Growth Conference

Oxford, UK, 3 August 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM:
SUMM), the drug discovery and development company advancing therapies
for Duchenne muscular dystrophy ('DMD') and Clostridium difficile
infection, announces that Mr Erik Ostrowski, CFO of Summit, will present
a corporate overview at the Canaccord Genuity Growth Conference on 9
August 2017 at 10:30am EDT in Boston, Massachusetts, US.

A live audio webcast of the presentation will be available through the
Investors section on the Company's website, www.summitplc.com.

football
03/8/2017
08:43
Morning Freedosh ... or:



Whatever it is ... it's moving very prettily!

hugus maximus
02/8/2017
21:27
Building the inverted head and shoulders of Notre-Dame
freedosh
02/8/2017
21:07
$14.34(3.02%) days high again
football
02/8/2017
14:36
SMMT on the move again it seems also SRPT?..gla lth's
abergele
02/8/2017
09:24
Solomon's query about the success of Sarepta's rights issue:
JUL 25, 2017 | BioCentury EXTRA

Sarepta Therapeutics Inc. (NASDAQ:SRPT) proposed to raise $250 million but actually raised $325.1 million through the sale of 7.7 million shares at $42.50.



Surely if Summit has even a hint of moderately successful data with DMD P2 24 week results in Q1, it becomes ripe for a takeover? Is this what's currently sustaining interest on the NASDAQ?

hugus maximus
31/7/2017
22:34
The end of July worked out really well ... 'look forward to August & September!
hugus maximus
Chat Pages: Latest  1554  1553  1552  1551  1550  1549  1548  1547  1546  1545  1544  1543  Older

Your Recent History

Delayed Upgrade Clock